Home > Technical section > Biomarkers > cancer biomarkers

cancer biomarkers

Thursday 22 April 2004

Tumor biomarkers

Cancer proteic biomarkers

The cancer proteic biomarkers are proteins found in the blood, tissues or urine that may be produced directly by a tumour or by other tissues in response to the presence of the tumour. They can therefore be used to screen for cancer and monitor the course of the disease.

See also

- biomarker discovery
- protein microarrays
- cancer proteic biomarkers

References

- Hinestrosa MC, Dickersin K, Klein P, Mayer M, Noss K, Slamon D, Sledge G, Visco FM. Shaping the future of biomarker research in breast cancer to ensure clinical relevance. Nat Rev Cancer. 2007 Apr;7(4):309-15. PMID: #17384585#

- Petricoin EF, Belluco C, Araujo RP, Liotta LA. The blood peptidome: a higher dimesion of information content for cancer biomarker discovery. Nat Rev Cancer. 2006 Nov 9; PMID: #17093504#

- Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer. 2005 Nov;5(11):845-56. PMID: #16239904#

- Furberg AH, Ambrosone CB. Molecular epidemiology, biomarkers and cancer prevention. Trends Mol Med. 2001 Nov;7(11):517-21. PMID: #11689338#